Dolby Laboratories (NYSE:DLB) CFO Sells $277,448.60 in Stock

Dolby Laboratories (NYSE:DLB) CFO Robert Park sold 4,895 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the transaction, the chief financial officer directly owned 81,490 shares in the company, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $54.24 on Friday. The stock has a market capitalization of $5.13 billion, a P/E ratio of 21.44 and a beta of 0.86. The business has a 50-day moving average of $61.11 and a two-hundred day moving average of $63.78. Dolby Laboratories has a fifty-two week low of $53.45 and a fifty-two week high of $77.59.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the prior year, the firm posted $1.34 EPS. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, research analysts expect that Dolby Laboratories will post 3.22 EPS for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be given a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.

Analyst Ratings Changes

Several research firms recently issued reports on DLB. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday, January 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $90.75.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of DLB. Royal Bank of Canada raised its stake in Dolby Laboratories by 3.5% during the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after purchasing an additional 2,298 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Dolby Laboratories by 218.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after purchasing an additional 171,288 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Dolby Laboratories by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock worth $19,131,000 after purchasing an additional 12,598 shares during the last quarter. Focus Partners Wealth bought a new position in shares of Dolby Laboratories during the 1st quarter worth about $390,000. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Dolby Laboratories by 273.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after purchasing an additional 1,902 shares during the period. 58.56% of the stock is currently owned by institutional investors and hedge funds.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.